Home

Orbis Investment Management reported a 5.5% stake in Crispr Therapeutics CRSP · 4,974,125 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.5%
Last report
First report
Shares held
4,974,125 sh
Class
Common Stock
Event date
25/09/30
Filed
25/11/14

First 5%+ report · 5.5% stake

Crispr Therapeutics trades, last 26 weeks

What else happened in Crispr Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Orbis Investment Management's other 5% stake reports

Orbis Investment Management reported a 5.5% stake in Crispr Therapeutics CRSP · 4,974,125 sh · passive holder | Whalegun